GIKLY
Price:
$6.16
Market Cap:
$7.35B
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-01-20
Stock Exchange
OTC
Ticker
GIKLY
According to Grifols, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.61B. This represents a change of 1.13% compared to the average of 15.44B of the last 4 quarters.
The mean historical Enterprise Value of Grifols, S.A. over the last ten years is 20.07B. The current 15.61B Enterprise Value has changed 7.68% with respect to the historical average. Over the past ten years (40 quarters), GIKLY's Enterprise Value was at its highest in in the December 2019 quarter at 28.06B. The Enterprise Value was at its lowest in in the September 2022 quarter at 0.
Average
20.07B
Median
20.10B
Minimum
15.33B
Maximum
27.90B
Discovering the peaks and valleys of Grifols, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 33.26%
Maximum Annual Enterprise Value = 27.90B
Minimum Annual Increase = -23.70%
Minimum Annual Enterprise Value = 15.33B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 15.33B | -23.70% |
| 2023 | 20.09B | 21.67% |
| 2022 | 16.51B | -17.96% |
| 2021 | 20.12B | -11.27% |
| 2020 | 22.68B | -18.71% |
| 2019 | 27.90B | 33.26% |
| 2018 | 20.93B | -4.83% |
| 2017 | 22.00B | 30.24% |
| 2016 | 16.89B | -7.34% |
| 2015 | 18.23B | 25.63% |
The current Enterprise Value of Grifols, S.A. (GIKLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.31B
5-year avg
18.94B
10-year avg
20.07B
Grifols, S.A.’s Enterprise Value is less than Astellas Pharma Inc. (4.26T), greater than Orion Oyj (8.69B), less than Astellas Pharma Inc. (4.26T), greater than bioMérieux S.A. (12.47B), less than CSPC Pharmaceutical Group Limited (72.85B), less than WuXi Biologics (Cayman) Inc. (117.12B), less than Fresenius Medical Care AG & Co. KGaA (21.20B), less than WuXi Biologics (Cayman) Inc. (117.12B), greater than Orion Oyj (8.69B), less than Smith & Nephew plc (17.20B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.26T | $21.91B | |
| 8.69B | $19.77B | |
| 4.26T | $22.89B | |
| 12.47B | $15.61B | |
| 72.85B | $10.85B | |
| 117.12B | $17.26B | |
| 21.20B | $13.48B | |
| 117.12B | $16.44B | |
| 8.69B | $11.43B | |
| 17.20B | $12.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Grifols, S.A.'s Enterprise Value?
What is the highest Enterprise Value for Grifols, S.A. (GIKLY)?
What is the 3-year average Enterprise Value for Grifols, S.A. (GIKLY)?
What is the 5-year average Enterprise Value for Grifols, S.A. (GIKLY)?
How does the current Enterprise Value for Grifols, S.A. (GIKLY) compare to its historical average?